| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,8 M € | +21.3% | 1,5 M € | +19.5% | 1,3 M € | +56.3% | 801,0 k € | -15.6% | 949,3 k € | +53.4% | 618,9 k € | -12.1% | 704,5 k € | +19.2% | 591,2 k € | +18.3% | 499,9 k € | -2.1% | 510,4 k € | -16.0% | 607,9 k € | +2.9% | 590,9 k € | +18.6% | 498,2 k € | +15.1% | 432,7 k € | -7.0% | 465,5 k € | -7.7% | 504,4 k € | -3.7% | 523,6 k € | -19.4% | 650,0 k € | |
| EBITDA | 1,5 M € | +37.1% | 1,1 M € | +7.3% | 986,4 k € | +35.2% | 729,6 k € | -20.0% | 911,9 k € | +53.2% | 595,1 k € | -14.2% | 693,6 k € | +21.5% | 571,0 k € | +14.6% | 498,0 k € | -2.0% | 508,4 k € | -16.0% | 605,6 k € | +2.9% | 588,7 k € | +19.0% | 494,6 k € | +15.5% | 428,3 k € | -7.4% | 462,8 k € | -8.0% | 502,8 k € | -3.6% | 521,7 k € | -19.5% | 648,4 k € | |
| Operating profit | 1,3 M € | +41.1% | 915,0 k € | +5.7% | 866,0 k € | +20.7% | 717,6 k € | -17.0% | 865,0 k € | +60.1% | 540,1 k € | +2.2% | 528,8 k € | +6.7% | 495,7 k € | +4.1% | 476,2 k € | -3.2% | 491,9 k € | -14.8% | 577,6 k € | +5.4% | 548,0 k € | +18.2% | 463,6 k € | +30.6% | 355,0 k € | -16.3% | 424,1 k € | -10.5% | 473,6 k € | -4.6% | 496,3 k € | -17.0% | 597,8 k € | |
| Profit/loss | 968,2 k € | +40.4% | 689,5 k € | +10.2% | 625,8 k € | +16.7% | 536,0 k € | -8.4% | 584,9 k € | +53.5% | 381,1 k € | +1.4% | 375,9 k € | +14.0% | 329,7 k € | -4.1% | 343,7 k € | -4.7% | 360,7 k € | -2.2% | 369,0 k € | -4.4% | 385,8 k € | +44.5% | 266,9 k € | -1.1% | 269,9 k € | -12.7% | 309,1 k € | -8.5% | 338,0 k € | -1.8% | 344,1 k € | -12.8% | 394,6 k € | |
| Equity | 7,7 M € | +14.3% | 6,8 M € | +11.4% | 6,1 M € | +11.5% | 5,4 M € | +10.9% | 4,9 M € | +13.4% | 4,3 M € | +9.7% | 3,9 M € | +10.5% | 3,6 M € | +10.2% | 3,2 M € | +11.9% | 2,9 M € | +14.2% | 2,5 M € | +17.3% | 2,2 M € | +11.4% | 1,9 M € | +15.9% | 1,7 M € | +19.2% | 1,4 M € | +28.2% | 1,1 M € | +44.5% | 758,7 k € | +83.0% | 414,6 k € | |
| Total assets | 8,1 M € | +15.9% | 7,0 M € | +11.4% | 6,2 M € | +12.7% | 5,5 M € | +10.2% | 5,0 M € | +12.1% | 4,5 M € | +10.8% | 4,1 M € | +8.0% | 3,8 M € | +12.0% | 3,4 M € | +10.5% | 3,0 M € | +15.6% | 2,6 M € | +19.2% | 2,2 M € | +11.8% | 2,0 M € | +14.4% | 1,7 M € | +18.9% | 1,4 M € | +29.4% | 1,1 M € | +33.9% | 835,9 k € | +36.8% | 611,1 k € | |
| Cash | 825,2 k € | +1172.4% | 64,9 k € | -83.3% | 388,7 k € | +196.2% | 131,2 k € | -88.1% | 1,1 M € | +26.3% | 874,2 k € | -33.3% | 1,3 M € | +29.9% | 1,0 M € | -46.7% | 1,9 M € | +19.9% | 1,6 M € | +404.8% | 313,0 k € | +41.1% | 221,8 k € | +39.0% | 159,6 k € | +10.5% | 144,4 k € | +213.9% | 46,0 k € | -56.4% | 105,5 k € | +416.5% | 20,4 k € | -58.1% | 48,7 k € | |
| Debts | 288,2 k € | +40.0% | 205,9 k € | +14.1% | 180,5 k € | +74.5% | 103,4 k € | +64.9% | 62,7 k € | -36.6% | 98,9 k € | +147.7% | 39,9 k € | -65.2% | 114,8 k € | +165.9% | 43,2 k € | -36.8% | 68,3 k € | +217.8% | 21,5 k € | -29.7% | 30,6 k € | +58.6% | 19,3 k € | +61.1% | 12,0 k € | -27.0% | 16,4 k € | +26.6% | 13,0 k € | -75.5% | 53,0 k € | -60.5% | 134,3 k € | |
| Staff | 9,2 | 10 | 6,6 | 1,6 | 0,7 | 0,5 | 0,3 | 0,3 | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||
Private limited company · Lebbeke · incorporated on 13/06/2007 · 9,2 ETP
Private limited company profitable and well capitalised. Cash position rising (+1172.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ORTHO-REVA is a Private limited company incorporated in 2007. Its main activity is: Specialist medical practice activities. Its registered office is in Lebbeke. It employs on average 9,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette